Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
60 results (top 60)
- 2상모집 예정· Ebola Virus Disease건강한 지원자에서 인마젭 투여와 에르베보 백신 접종 사이의 시간 간격이 백신 면역반응에 미치는 영향
Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers
협력: 리제네론
- 2상모집 예정· Lung Cancer (NSCLC)절제 가능한 고PD-L1 비소세포폐암에 대한 수술 전후 세미플리맙 투여
Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1
협력: 리제네론
- 2상모집 예정· Non Small Cell Lung Cancer의학적 수술 불가능 1기 비소세포폐암에서 급진적 치료 없이 면역치료 3주기 사용
RADICAL-IO: thRee Cycles of immunotherApy Without raDical Therapy In mediCALly InOperable Stage I Non-small Cell Lung Cancer
협력: 리제네론
- 2상모집 예정· Locally Advanced Basal Cell Carcinoma국소 진행성 기저 세포 피부암 성인 환자를 위한 Cemiplimab 기반 치료법 비교 연구
A Study Comparing Cemiplimab-based Treatments for Adult Participants With Locally Advanced Basal Cell Skin Cancer (laBCC)
리드: 리제네론
- 2상모집 예정· Colon Cancer절제 가능한 비전이성 결장암에 대한 세미플리맙과 피안리맙
Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer
협력: 리제네론
- 2상모집 예정· Kidney Transplant Recipient진행된 피부 편평세포암종을 가진 신장 이식 환자에서의 세미플리맙
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
협력: 리제네론
- 2상철회· Bladder Urothelial Carcinoma방광암 환자의 방사선 요법과 세미플리맙 ± 피알리맙 병합 연구
A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer
협력: 리제네론
- 2상모집 예정· NsclcPD-L1 고발현 절제 가능한 비소세포폐암에 대한 적응형 화학요법: Chemo-PHREE 임상시험
Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial
협력: 리제네론
- 2상모집 예정· Glioblastoma재발성 교모세포종에서 레이저 조직간 온열치료(LiTT)와 Cemiplimab 또는 화학치료 병용
Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas
협력: 리제네론
- 2상모집 중· Colon and Rectal Cancer국소 진행 담도계암에 대한 겜시타빈, 시스플라틴, 나브-파클리탁셀(GAP) 및 세미플리맙 투여
Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
협력: 리제네론
- 2상모집 중· Non-small Cell Lung Cancer Stage IIIN3 림프절 침범이 있는 국소진행성 비소세포폐암의 신보조 화학면역치료 및 수술적 절제
Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features
협력: 리제네론
- 2상모집 중· Overweight or Obesity당뇨병이 없는 과체중 또는 비만 성인 참여자를 대상으로 한 올라토레파티드 연구
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
리드: 리제네론
- 2상모집 예정· Metabolic Dysfunction-Associated Steatohepatitis (MASH)섬유화성 대사이상 연관 지방간염(MASH) 성인에서 ALN-CIDEB을 평가하는 연구
Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
리드: 리제네론
- 2상모집 중· Colorectal Cancer국소진행 직장암의 신보조 치료에서 카페시타빈/옥살리플라틴과 세미플리맙, 피안리맙 또는 REGN7075 병용
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
협력: 리제네론
- 2상모집 중· Hypercholesterolemia고콜레스테롤혈증 환자에게 주 1회 투여되는 알리로쿠맙의 안전성 및 효과 평가
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
리드: 리제네론
- 2상모집 중· Merkel Cell Carcinoma, Stage IPD-1 억제제 세미플리맙을 이용한 머클세포암종 신보조 치료
Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab
협력: 리제네론
- 2상모집 중· Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)동형접합 PNPLA3 관련 MASLD 성인 환자에서 ALN-PNP와 GLP-1 수용체 작용제 병용 여부에 관한 2a상 연구
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
리드: 리제네론
- 2상모집 중· Pulmonary Arterial Hypertension (PAH)폐동맥 고혈압(PAH) 성인 참가자에서의 REGN13335 연구
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
리드: 리제네론
- 2상모집 중· Pancreatic Ductal Adenocarcinoma (mPDAC)전이성 췌장 선암종 환자에서의 세미플리맙 및 겜시타빈 병합 치료
Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
협력: 리제네론
- 2상모집 중· Advanced Renal Cell Carcinoma (aRCC)1차 진행된 신세포암종에서 피아닐리맙/세미플리맙 ± 이필리무맙 또는 이필리무맙/니볼루맙의 무작위 배정 2상 시험
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
협력: 리제네론
- 2상모집 중· Colo-rectal Cancer결장직장암 수술 및 화학요법 후 미세잔존질환 환자를 대상으로 세미플리맙 단독요법 또는 세미플리맙 플러스 피안리맙 또는 기타 신규 병합요법의 치료효과를 평가하는 2상 플랫폼 연구 (EMPIRE)
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
협력: 리제네론
- 2상모집 중· Head and Neck Squamous Cell Carcinoma (HNSCC)재발성 또는 전이성 두경부 편평세포암종에서 피안리맙과 세미플리맙 병용 효과 연구
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
리드: 리제네론
- 2상모집 중· Pleural MesotheliomasTrial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma
협력: 리제네론
- 2상모집 중단 (진행 중)· Overweight or ObesityStudy of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US
리드: 리제네론
- 2상모집 중· Functional Hypothalamic Amenorrhea (FHA)A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
리드: 리제네론
- 2상모집 중· Clear Cell Renal Cell CarcinomaCemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma
협력: 리제네론
- 2상모집 중· Diabetic Kidney Disease (DKD)Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
리드: 리제네론
- 2상모집 중· NSCLC (Advanced Non-small Cell Lung Cancer)Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
협력: 리제네론
- 2상모집 중· Atrial Fibrillation (AF)Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
리드: 리제네론
- 2상모집 중· Recurrent Diffuse Large B-Cell LymphomaOdronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
협력: 리제네론
- 2상모집 중· Basal Cell Carcinoma (BCC)Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients
협력: 리제네론
- 2상모집 중· Solid TumorsPhase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors
협력: 리제네론, 사노피
- 2상모집 중· Melanoma BRAF V600E/K MutatedEncorafenib and biNimetinib Followed by CEmiplimab and FiAnLimab in Patients With BRAF Mutant melanOma and Symptomatic Brain Metastases
협력: 리제네론
- 2상모집 중단 (진행 중)· Head and Neck Squamous Cell CarcinomaPhase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC
협력: 일라이 릴리, 리제네론
- 2상모집 중· Carcinoma, Non-Small-Cell LungPreoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
협력: 리제네론
- 2상완료· Chronic Rhinosinusitis Without Nasal PolypsA Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps
리드: 사노피 · 협력: 리제네론
- 2상모집 중· PruritisDupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic
협력: 리제네론
- 2상모집 중· Locally Recurrent Oral Cavity Squamous Cell CarcinomaCemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma
협력: 리제네론
- 2상모집 중단 (진행 중)· Non-Small Cell Lung CancerA Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
리드: 리제네론
- 2상완료· Postural Orthostatic Tachycardia Syndrome (POTS)Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)
리드: 리제네론
- 2상모집 중· Metastatic Uveal MelanomaStudy of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
협력: 리제네론, 사노피
- 2상모집 중단 (진행 중)· SMARCB1-Deficient MalignanciesPhase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies
협력: 리제네론
- 2상모집 중단 (진행 중)· Non-Transfusion Dependent Beta-Thalassemia (NTDT)A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body
리드: 리제네론
- 2상모집 중· Monoclonal Gammopathy of Undetermined Significance (MGUS)A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
리드: 리제네론
- 2상모집 중· Advanced MelanomaA Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
협력: 리제네론
- 2상모집 중단 (진행 중)· Resectable Non-small Cell Lung CancerA Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
리드: 리제네론
- 2상모집 중· Colorectal CancerCemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
협력: 리제네론
- 2상모집 중단 (진행 중)· Colon CancerThe Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer
협력: 리제네론
- 2상모집 중단 (진행 중)· Smoldering Multiple Myeloma (SMM)A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma
리드: 리제네론
- 2상모집 중단 (진행 중)· Cutaneous Squamous Cell CarcinomaDeep sequencIng in Cutaneous Squamous CEll caRciNomas
협력: 리제네론, 사노피
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.